A future directions of renal cell carcinoma treatment: combination of immune checkpoint inhibition and carbon ion radiotherapy
Renal cell carcinoma (RCC) is considered radio- and chemo-resistant. Immune checkpoint inhibitors (ICIs) have demonstrated significant clinical efficacy in advanced RCC. However, the overall response rate of RCC to monotherapy remains limited. Given it…